Gabapentin Tablet, Film Coated
Product Images NDC 71335-1007

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

Figure 1 (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)
This appears to be a formula for calculating creatinine clearance (CLOr) in patients based on their age, weight, and serum creatinine levels. The formula is adjusted for female patients by multiplying the result by 0.85.*
FDA Label Image

Chem Structure (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

Chem Structure (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)
FDA Label Image

Figure01 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

Figure01 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)
FDA Label Image

Figure02 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

Figure02 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)
This is a chart showing the mean pain score during a 4-week fixed dose period, marked as "Baseline 1 2 3 4 5 s 7". The treatment options being compared are "o-Placebo," "Gabapentin, 1800 mg/day," and "Gabapentin, 2400 mg/day."*
FDA Label Image

Figure03 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

Figure03 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)
This text represents the results of a study on pain relief medication for PHN (post-herpetic neuralgia). Figure 3 shows the percentage of patients who experienced more than 50% pain reduction as a result of using the medication at the end of the study. The results are shown for two controlled studies (Study 1 and Study 2), and the percentage of responders is different for each study. The study compares the effects of medication to a placebo control group represented by the abbreviation "PBO" (a group of patients who did not receive the medication). The data also indicates the cost of the medication (GBP 3600) and placebo (GBP 1800) used in the study.*
FDA Label Image

Figure4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

Figure4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)
FDA Label Image

Label Image (Lbl713351007)

Label Image (Lbl713351007)
This text appears to be a label of a medication, containing information about the manufacturer, dosage, and storage instructions. It is a comparison between the medication labeled "Neurontin 800mg Tablet" and another medication, packaged by "Bryant Ranck Prepack". The label also includes information about the expiration date, NDC number, and storage temperature. The medication should be kept out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.